Sherbrooke Park Advisers’s CareDx CDNA Stock Holding History

Sherbrooke Park Advisers’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-22,197	Closed	-$394K	–	545
2025 Q1	$394K	Sell	22,197 -3,603	-14%	-$77.6K	0.18%	203
2024 Q4	$552K	Buy	25,800 +17,885	+226%	+$435K	0.18%	178
2024 Q3	$247K	Buy	+7,915	New	+$197K	0.06%	663
2023 Q4	–	Sell	-12,212	Closed	-$85.5K	–	480
2023 Q3	$85.5K	Buy	+12,212	New	+$113K	0.03%	466

Other funds holding CDNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

Sherbrooke Park Advisers's CDNA Position: Q2 2025 in Review

Sherbrooke Park Advisers sold out of CareDx (CDNA) in Q2 2025, closing a stake of 22,197 shares — an estimated $394K sold.

Sherbrooke Park Advisers first reported a position in CDNA in Q3 2023 and held it in 4 quarters. The position peaked at $552K in Q4 2024. 197 funds tracked by Wall St. Rank hold CDNA as of Q2 2025.

Sherbrooke Park Advisers reported no remaining CareDx position as of Q2 2025 after selling out during the quarter.
Sherbrooke Park Advisers sold 22,197 CareDx shares in Q2 2025, an estimated $394K.
Sherbrooke Park Advisers first reported a position in CareDx in Q3 2023 and held it in 4 quarters.
Sherbrooke Park Advisers's CareDx position peaked at $552K in Q4 2024.
197 funds tracked by Wall St. Rank held CareDx as of Q2 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.